ArticleThe Kaohsiung journal of medical sciences2026
Composite Inflammatory Score for Predicting Progression-Free Survival in Metastatic Clear Cell Renal Cell Carcinoma Treated With First-Line Toripalimab Plus Axitinib.
Yun-Feng Wu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.